These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1271 related items for PubMed ID: 9695990
1. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy. Chazouillères O, Wendum D, Serfaty L, Montembault S, Rosmorduc O, Poupon R. Hepatology; 1998 Aug; 28(2):296-301. PubMed ID: 9695990 [Abstract] [Full Text] [Related]
2. Long term outcome and response to therapy of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. Chazouillères O, Wendum D, Serfaty L, Rosmorduc O, Poupon R. J Hepatol; 2006 Feb; 44(2):400-6. PubMed ID: 16356577 [Abstract] [Full Text] [Related]
3. Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid. Joshi S, Cauch-Dudek K, Wanless IR, Lindor KD, Jorgensen R, Batts K, Heathcote EJ. Hepatology; 2002 Feb; 35(2):409-13. PubMed ID: 11826416 [Abstract] [Full Text] [Related]
4. [Clinical features of 35 cases of autoimmune hepatitis-primary biliary cirrhosis overlap syndrome]. Zeng Z, Han YK, Zhang XF, Geng H. Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):3-5. PubMed ID: 15670480 [Abstract] [Full Text] [Related]
5. Clinical and biochemical features and therapy responses in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. Günsar F, Akarca US, Ersöz G, Karasu Z, Yüce G, Batur Y. Hepatogastroenterology; 2002 Jan; 49(47):1195-200. PubMed ID: 12239904 [Abstract] [Full Text] [Related]
6. [Primary biliary cirrhosis and autoimmune hepatitis overlap syndrome: therapeutic features in 5 patients]. Cheikh I, Said Y, Chaabouni H, Ouerghi H, Ben Ammar A. Ann Med Interne (Paris); 2003 Feb; 154(1):7-11. PubMed ID: 12746654 [Abstract] [Full Text] [Related]
7. [Clinical features of 107 autoimmune hepatitis patients and 30 of them with AIH-primary biliary cirrhosis overlap syndrome]. Qiu DK, Li XM, Wei J, Ye LJ, Peng YS, Ma X. Zhonghua Gan Zang Bing Za Zhi; 2008 May; 16(5):367-71. PubMed ID: 18510851 [Abstract] [Full Text] [Related]
8. Therapy response and outcome of overlap syndromes: autoimmune hepatitis and primary biliary cirrhosis compared to autoimmune hepatitis and autoimmune cholangitis. Ozaslan E, Efe C, Akbulut S, Purnak T, Savas B, Erden E, Altiparmak E. Hepatogastroenterology; 2010 May; 57(99-100):441-6. PubMed ID: 20698205 [Abstract] [Full Text] [Related]
9. Overlap of primary biliary cirrhosis and autoimmune hepatitis: Characteristics, therapy, and long term outcomes. Yokokawa J, Saito H, Kanno Y, Honma F, Monoe K, Sakamoto N, Abe K, Takahashi A, Yokokawa H, Ohira H. J Gastroenterol Hepatol; 2010 Feb; 25(2):376-82. PubMed ID: 19817953 [Abstract] [Full Text] [Related]
12. [Observation on therapeutic alliance with UDCA and glucocorticoids in AIH-PBC overlap syndrome]. Zhu JY, Shi YQ, Han ZY, Jia G, Li ZS, Huang XF, Wang JH, Wang RA, Zhou XM, Han Y. Zhonghua Gan Zang Bing Za Zhi; 2011 May; 19(5):334-9. PubMed ID: 21645439 [Abstract] [Full Text] [Related]
14. Factors associated with response to therapy and outcome of patients with primary biliary cirrhosis with features of autoimmune hepatitis. Ozaslan E, Efe C, Heurgué-Berlot A, Kav T, Masi C, Purnak T, Muratori L, Ustündag Y, Bresson-Hadni S, Thiéfin G, Schiano TD, Wahlin S, Muratori P. Clin Gastroenterol Hepatol; 2014 May; 12(5):863-9. PubMed ID: 24076417 [Abstract] [Full Text] [Related]
15. Development of autoimmune hepatitis in primary biliary cirrhosis. Gossard AA, Lindor KD. Liver Int; 2007 Oct; 27(8):1086-90. PubMed ID: 17845536 [Abstract] [Full Text] [Related]
16. Biochemical markers of liver fibrosis and lymphocytic piecemeal necrosis in UDCA-treated patients with primary biliary cirrhosis. Corpechot C, Poujol-Robert A, Wendum D, Galotte M, Chrétien Y, Poupon RE, Poupon R. Liver Int; 2004 Jun; 24(3):187-93. PubMed ID: 15189267 [Abstract] [Full Text] [Related]
17. A randomized trial comparing colchicine and ursodeoxycholic acid combination to ursodeoxycholic acid in primary biliary cirrhosis. UDCA-PBC Study Group. Poupon RE, Huet PM, Poupon R, Bonnand AM, Nhieu JT, Zafrani ES. Hepatology; 1996 Nov; 24(5):1098-103. PubMed ID: 8903382 [Abstract] [Full Text] [Related]
18. The serological profile of the autoimmune hepatitis/primary biliary cirrhosis overlap syndrome. Muratori P, Granito A, Pappas G, Pendino GM, Quarneti C, Cicola R, Menichella R, Ferri S, Cassani F, Bianchi FB, Lenzi M, Muratori L. Am J Gastroenterol; 2009 Jun; 104(6):1420-5. PubMed ID: 19491855 [Abstract] [Full Text] [Related]
19. Treatment of primary biliary cirrhosis. Poupon R, Poupon RE. Baillieres Best Pract Res Clin Gastroenterol; 2000 Aug; 14(4):615-28. PubMed ID: 10976018 [Abstract] [Full Text] [Related]
20. [Presence of SLA/LP autoantibodies in patients with primary biliary cirrhosis as a marker for secondary autoimmune hepatitis (overlap syndrome)]. Kanzler S, Bozkurt S, Herkel J, Galle PR, Dienes HP, Lohse AW. Dtsch Med Wochenschr; 2001 Apr 20; 126(16):450-6. PubMed ID: 11360449 [Abstract] [Full Text] [Related] Page: [Next] [New Search]